Skip To Main Content
Achal S Achrol on Muck Rack

Achal S Achrol

As seen in: Future Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Achal S

Contact Achal S, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Biological intratumoral therapy for the high-grade glioma part II: vector- and cell-based therapies and radioimmunotherapy

|
By Joshua Loya, Charlie Zhang, Emily Cox, Achal S Achrol
| Future Medicine Verified
Considerable innovations in biological treatment agents for high-grade gliomas (HGGs) have occurred over the preceding decades. Given HGGs inherent invasion of functional neural tissue it is an essential part of a tolerable and effective treatment to minimize collateral effects on normal tissues while effectively targeting neoplastic cells.
Open in Who Shared Issue with article?

Biological intratumoral therapy for the high-grade glioma part I: intratumoral delivery and immunotoxins

|
By Charlie Zhang, Emily Cox, Joshua Loya, Achal S Achrol
| Future Medicine Verified
High-grade gliomas (HGGs) remain the most challenging primary brain neoplasms to treat and necessitate a multimodal therapeutic approach. With an incidence of 5 per 100,000 they are the most common malignant brain neoplasm, and despite advancements in treatment over the last several decades, mortality remains high with a 1-year survival of 35.7% for glioblastoma and ranging from 60 to 80% for WHO grade III tumors [1].
Open in Who Shared Issue with article?
See all 2 articles